Toronto, Canada, January 20, 2022 - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that the Company plans to implement a roll up strategy focused on Artificial Intelligence ("AI") companies in 2022. As previously announced on January 18, 2022, the Company currently has approximately $20 million in cash and cash equivalent.

As artificial intelligence is becoming a growing influence in business, Datametrex is poised to leverage its AI experience to help reshape the entire industry. Over the last few years, the Company has landed significant AI contracts globally with many entities including International Conglomerates, Government Agencies and Ministries, Financial Services, and International Airports.

"As a CEO with a strong computer science background, I have seen AI produce huge changes to how we conduct our lives, from basic machine learning to business intelligence and automation to analytics; the possibilities are endless. We feel this opens the door to grow Datametrex exponentially by adding businesses and becoming leaders in these emerging technologies," commented Marshall Gunter, CEO of Datametrex.

According to as quoted by Forbes "AI contributed a whopping $2 trillion to global GDP last year. By 2030, it could be as much as $15.7 trillion, making it the biggest commercial opportunity in today's fast-changing economy," (Sourced online January 13, 2022)

For more information on this project or to learn how Datametrex can assist your organization in social media discovery or cyber security please go to:

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain.

For additional information on Datametrex and other corporate information, please visit the Company's website at .

For further information, please contact:
Marshall Gunter - CEO
Phone: (514) 295-2300
Email:

Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements:

All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company's control. In particular, there is no guarantee that the parties will successfully negotiate and enter into a definitive agreement on mutually acceptable terms or complete the Transaction in the manner contemplated herein, if at all, that the due diligence of any of the parties will be satisfactory, or that the parties will obtain any required board, shareholder, third-party and/or regulatory or other governmental approvals, if any. Readers should not place undue reliance on forward-looking statements. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.